TTR and poikiloderma with neutropenia: To establish the proteomic profiles for each experimental group, we analyzed plasma samples from 12 untreated V30M ATTRv-PN patients, 8 asymptomatic V30M carriers, and 4 healthy (WT TTR only) controls; patient samples were chosen at random from our biobank [23].